A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice

Published:2012-06-21 Issue:7 Volume:28 Page:1079-1087
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Van Belle S.¹,Swieboda-Sadlej A.²,Karanikiotis C.³,Labourey J.-L.⁴,Galid A.⁵,Wheeler T.⁶,Pujol B.⁷,Aerts J.G.⁸⁹

Affiliation:

1. Department of Medical Oncology, University Hospital Ghent GhentBelgium

2. Department of Hematology and Oncology, Medical University of Warsaw WarsawPoland

3. Euromedica – Kyanous Stavros Hospital TheassalonikiGreece

4. Centre Hospitalier Antoine Gayraud CarcassonneFrance

5. Gynecology and Obstetrics Hanusch KH, ViennaAustria

6. Amgen Ltd UxbridgeUK

7. Amgen (Europe) GmbH ZugSwitzerland

8. Department of Pulmonary Diseases, Amphia Hospital BredaThe Netherlands

9. Department of Pulmonary Diseases, Erasmus MC RotterdamThe Netherlands

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2012.698601

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Cresp® in the management of chemotherapy-induced anemia in cancer patients: A real-world clinical practice audit;South Asian Journal of Cancer;2020-01

2. Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status;Clinical Colorectal Cancer;2018-03

3. Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL;Clinical Therapeutics;2016-01

4. Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study;Future Oncology;2015-06

5. Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction;Frontiers in Immunology;2014-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3